MetaCap

Celldex Therapeutics Insider Trades

NASDAQ: CLDXHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD

27.42-0.54 (-1.93%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
1 · $121.21K
Shares bought / sold
0 / 4.17K
Net activity
Net selling $121,210

Celldex Therapeutics insider activity

Over the last 12 months, Celldex Therapeutics insiders reported 4 transactions on SEC Form 4: 0 open-market purchases and 1 sale. Insiders bought $0 and sold $121,210 worth of stock, for net insider selling of $121,210. The largest seller was Jimenez Freddy A., with $121,210 in reported sales.

The most recent filing shows Martin Samuel Bates (SVP AND CFO) reporting a transaction in 4,817 shares at $10.38 on Jan 2, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put CLDX's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

CLDX insider transactions

Celldex Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Jan 2, 2026Martin Samuel BatesSVP AND CFOOption exercise4,817$50.00KForm 4
Dec 15, 2025PEPIN RONALDSR. VP & CBOOption exercise11,000$30.58KForm 4
Dec 15, 2025PEPIN RONALDSR. VP & CBOOption exercise8,333$75.13KForm 4
Dec 4, 2025Jimenez Freddy A.SVP & GENERAL COUNSELSale4,166$121.21KForm 4
Nov 13, 2025Wright Richard M.Former OfficerSale49,298$1.18MForm 4
Nov 13, 2025Wright Richard M.Former OfficerOption exercise15,750$354.06KForm 4
Nov 13, 2025Wright Richard M.Former OfficerOption exercise26,672$276.86KForm 4
Nov 13, 2025Wright Richard M.Former OfficerOption exercise6,876$62.00KForm 4
Aug 13, 2025Jimenez Freddy A.SVP & GENERAL COUNSELSale430$10.93KForm 4
Aug 13, 2025Jimenez Freddy A.SVP & GENERAL COUNSELSale341$8.17KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related